(3aR)-5-Chloro-2,11,12,24,27,29-hexahydro-2,3,24,33-tetramethyl-22H-9,4,8-(metheniminomethyno)-14,20:26,23-dimetheno-10H,20H-pyrazolo[4,3-l][2,15,22,18,19]benzoxadithiadiazacyclohexacosine-32-carboxylic acid
- Catalog No. :
- ACGCZU642
- CAS No. :
- 2143061-81-6
- Molecular Formula :
- C35H34ClN5O3S2
- Molecular Weight :
- 672.28
IUPAC Name:16-Chloro-11,21,25,61-tetramethyl-11H,21H,61H-10-oxa-4,8-dithia-1(7,3)-indola-2(4,3),6(3,5)- dipyrazola-9(3,1)-naphthalenacyclotridecaphane-12-carboxylic acid
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg99%$127.00Login to see priceIn stockInquiry
10mg99%$204.00Login to see priceIn stockInquiry
25mg99%$406.00Login to see priceIn stockInquiry
50mg99%$689.00Login to see priceIn stockInquiry
Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.
0 Reviews:View Reviews
Product Information
| Product Name | (3aR)-5-Chloro-2,11,12,24,27,29-hexahydro-2,3,24,33-tetramethyl-22H-9,4,8-(metheniminomethyno)-14,20:26,23-dimetheno-10H,20H-pyrazolo[4,3-l][2,15,22,18,19]benzoxadithiadiazacyclohexacosine-32-carboxylic acid |
|---|---|
| IUPAC Name | 16-Chloro-11,21,25,61-tetramethyl-11H,21H,61H-10-oxa-4,8-dithia-1(7,3)-indola-2(4,3),6(3,5)- dipyrazola-9(3,1)-naphthalenacyclotridecaphane-12-carboxylic acid |
| MDL No. | MFCD31807622 |
| Molecular Formula | C35H34ClN5O3S2 |
| Molecular Weight | 672.28 |
| SMILES | O=C(O)C1=C(CCCOC2=C3C(C=CC=C3)=CC(SCC4=CC(CSCC5=NN(C)C(C)=C56)=NN4C)=C2)C7=CC=C(Cl)C6=C7N1C |
| InChI Key | KBQCEQAXHPIRTF-UHFFFAOYSA-N |
| Synonym | 2143061-82-7 | AZD 5991 | US10196404, Example 1 | A16880 | 17-chloro-5,13,14,22-tetramethyl-28-oxa-2,9-dithia-5,6,12,13,22-pentazaheptacyclo[27.7.1.14,7.011,15.016,21.020,24.030,35]octatriaconta-1(36),4(38),6,11,14,16,18,20,23,29(37),30,32,34-tridecaene-2 |
| CAS No. | 2143061-81-6 |
| PubChem CID | 131634760 |
Safety Data
- Pictogram
- Signal Word
- Warning
- Hazard Statement(s)
- H302-H315-H319-H335
- Precautionary Statement(s)
- P261-P305+P351+P338
